発表施設 題 氏名 発表 発表年 愛知県がんセン 2013年 ター中 …

← Back to document page

Functional variants at the 11q13 risk locus forbreast cancer regulate cyclin D1 expressionthrough long-range enhancersFrench JD, Ghoussaini M, Edwards SL, Meyer KB,Michailidou K, Ahmed S, Khan S, Maranian MJ,O'Reilly M, Hillman KM, Matsuo K, Ito H, Iwata H,Sueta A, Nevanlinna H, Brown MA, Chenevix-Trench G, Easton DF, Dunning AM et J Hum Genet, 92(4):489-503,20132013 Fine-Scale Mapping of the FGFR2 BreastCancer Risk Locus: Putative Functional VariantsDifferentially Bind FOXA1 and E2F1Meyer KB, O'Reilly M, Michailidou K, Carlebur S,Edwards SL, French JD, Prathalingham R, Dennis J,Bolla MK, Wang Q, Matsuo K, Ito H, Iwata H,Yatabe Y, Orr N, Schoemaker MJ, Ponder BA,Dunning AM, Easton DF et J Hum Genet, 93(6):1046-60,20132013 High-Throughput LC-MS/MS BasedSimultaneous Determination of PolyaminesIncluding N-Acetylated Forms in Human Salivaand the Diagnostic Approach to Breast CancerTsutsui H, Mochizuki T, Inoue K, Toyama T,Yoshimoto N, Endo Y, Todoroki K, Min JZ,Toyo'oka TAnal Chem, 85(24):11835-42, 20132013 Sivelestat attenuates lung injury in surgery forcongenital heart disease with pulmonaryhypertensionNomura N, Asano M, Saito T, Nak

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluoracil-epirubicin-cyclophosphamide (FEC) in early stage breast cancer: Exploratory analyses

  Capecitabine